GO:1903679 positive regulation of cap-independent translational initiation: Translational Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903679 describes any process that activates or increases the frequency, rate or extent of cap-independent translational initiation, a mode of protein synthesis that bypasses the m7G cap requirement.
• Cap-independent initiation is driven mainly by internal ribosome entry sites (IRESs) and 3' cap-independent translation enhancers (3' CITEs), which recruit ribosomes directly or enhance initiation.
• Positive regulators include RNA structural elements, RNA-binding proteins, and chemical modifications such as N6-methyladenosine that promote translation of specific mRNAs.
• This process is central to viral gene expression, especially in picornaviruses, flaviviruses, and hepatoviruses, and to cellular stress responses.
• Dysregulation of cap-independent initiation is linked to cancer angiogenesis and viral pathogenesis, making it a target for therapeutic intervention.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of positive regulators of cap-independent initiation.
Description
Cap-independent translational initiation is a mechanism by which ribosomes are recruited to an mRNA without relying on the 5' m7G cap structure. This alternative route is essential when cap-dependent translation is compromised, such as during viral infection or cellular stress. GO:1903679, positive regulation of cap-independent translational initiation, encompasses any process that activates or increases the frequency, rate or extent of this initiation mode. Understanding this term is critical because it governs the expression of key viral and cellular proteins under conditions where canonical translation is suppressed. Research has identified diverse positive regulators, including internal ribosome entry sites (IRESs), 3' cap-independent translation enhancers (3' CITEs), RNA-binding proteins, and RNA modifications. These elements and factors are being dissected using advanced CRISPR models and translation profiling, offering insights into viral pathogenesis and cancer biology.
positive regulation of cap-independent translational initiation At A Glance
| GO ID | GO:1903679 |
|---|---|
| GO term | positive regulation of cap-independent translational initiation |
| Ontology | biological_process |
| Synonym | activation of cap-independent translational initiation; up regulation of cap-independent translational initiation; up-regulation of cap-independent translational initiation; upregulation of cap-independent translational initiation |
| Major function | Enhances the initiation of protein synthesis in a cap-independent manner, often via IRESs or 3' CITEs |
| Related processes | Viral translation, stress-responsive translation, angiogenesis |
| Key regulators | RNA structures, RNA-binding proteins, m6A modification |
| Disease relevance | Cancer, viral infections |
What Is GO:1903679?
GO:1903679 is a biological process term defined as any process that activates or increases the frequency, rate or extent of cap-independent translational initiation. In other words, it covers the positive regulation of the step that starts protein synthesis on an mRNA without the need for a 5' cap. This regulation can be mediated by RNA sequences, structural elements, proteins, or chemical modifications that enhance the recruitment of the translation machinery.
Why Is positive regulation of cap-independent translational initiation Important in Cell Biology?
Positive regulation of cap-independent translational initiation is vital because it allows cells and viruses to sustain protein synthesis when cap-dependent translation is inhibited, such as during stress or infection. This process is exploited by many RNA viruses to produce their proteins and is also used by cellular mRNAs involved in survival, angiogenesis, and stress responses. Consequently, it represents a key node for therapeutic intervention in viral diseases and cancer.
• Enables viral protein synthesis when cap-dependent translation is shut down.
• Supports cellular stress responses and survival under adverse conditions.
• Drives angiogenesis in lung cancer via m6A-mediated VEGFA translation.
• Involved in picornavirus and flavivirus gene expression.
• Regulated by RNA structural elements like IRESs and 3' CITEs.
• Targeted by RNA modifications such as N6-methyladenosine.
• Potential therapeutic target for antiviral and anticancer strategies.
• Requires advanced models to dissect causal roles of regulators.
What Happens During positive regulation of cap-independent translational initiation?
Recruitment of ribosomes to cap-independent elements
In simple terms: Instead of using the cap, the ribosome is recruited directly to special RNA structures.
Positive regulation often involves enhancing the recruitment of the 40S ribosomal subunit to internal ribosome entry sites (IRESs) or 3' cap-independent translation enhancers (3' CITEs). These RNA elements can fold into complex structures that directly bind translation initiation factors or ribosomal components, bypassing the need for the cap-binding complex.
Role of RNA-binding proteins
In simple terms: Proteins can bind to the RNA and help start translation without the cap.
Specific RNA-binding proteins act as positive regulators by stabilizing RNA structures or recruiting initiation factors. For example, PDGFA-associated protein 1 (PDAP1) is an eIF4E-binding protein that regulates endoplasmic reticulum stress responses and is required for hepatovirus translation. Other proteins may similarly enhance cap-independent initiation.
Contribution of RNA modifications
In simple terms: Chemical marks on RNA can make translation start more efficiently.
N6-methyladenosine (m6A) modification promotes the translation of specific mRNAs, such as VEGFA, by facilitating cap-independent initiation. This modification can create binding sites for reader proteins that recruit ribosomes or initiation factors, thereby positively regulating translation.
Impact of RNA structure and G-quadruplexes
In simple terms: RNA folding can either help or hinder translation, depending on context.
G-quadruplexes can reverse their role in translation control when present in the context of an IRES, acting as positive regulators of cap-independent initiation. Similarly, the genomic 3' UTR of flaviviruses acts as a translation initiation enhancer, highlighting the importance of RNA structure in positive regulation.
Viral exploitation of cap-independent initiation
In simple terms: Viruses use these mechanisms to make their proteins even when the cell's normal translation is blocked.
Positive-strand RNA viruses, including picornaviruses and flaviviruses, rely on cap-independent initiation to translate their genomes. They often encode IRESs or 3' CITEs that are positively regulated by viral or host factors, ensuring efficient viral protein synthesis.
Key Genes Involved in GO:1903679 positive regulation of cap-independent translational initiation
The following genes and proteins are key players in the positive regulation of cap-independent translational initiation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDAP1 | eIF4E-binding protein regulating ER stress and hepatovirus translation | Required for hepatovirus translation; potential target for antiviral research |
| VEGFA | m6A-modified mRNA translated cap-independently to promote angiogenesis | Model for studying m6A in cap-independent translation in cancer |
| EIF4G | Scaffold protein for initiation; can be recruited to IRESs | Central to both cap-dependent and cap-independent initiation |
| EIF4A | RNA helicase aiding ribosome scanning | Target for inhibitors affecting IRES-mediated translation |
| PTBP1 | IRES trans-acting factor (ITAF) | Modulates picornavirus IRES activity |
| ITAFs (e.g., PCBP2, hnRNPC) | Enhance IRES-mediated initiation | Diverse roles in viral and cellular IRES translation |
| RPS25 | Ribosomal protein required for IRES translation | Potential target for selective inhibition of IRES |
| METTL3 | m6A writer that promotes cap-independent translation | Therapeutic target in cancer angiogenesis |
| YTHDF1 | m6A reader enhancing translation | Mediates m6A-dependent cap-independent initiation |
| G-Quadruplex structures | RNA structures that can enhance IRES-mediated translation | Context-dependent regulators |
| 3' CITEs | RNA elements enhancing cap-independent translation | Key for plant virus translation |
| Flavivirus 3' UTR | Acts as translation initiation enhancer | Target for antiviral development |
| Hepatovirus IRES | Directly recruits ribosomes | Model for studying PDAP1 dependence |
| Picornavirus IRES | Classic example of cap-independent initiation | Well-studied for ITAF requirements |
| eIF4E | Cap-binding protein; its sequestration can trigger cap-independent translation | Indirect positive regulator by limiting cap-dependent translation |
| eIF2α | Initiation factor regulated by stress | Its phosphorylation can favor IRES-mediated translation |
| La autoantigen | ITAF for several IRESs | Enhances translation of viral and cellular mRNAs |
How Is positive regulation of cap-independent translational initiation Regulated?
Positive regulation of cap-independent translational initiation is controlled at multiple levels. Cellular stress, such as ER stress or viral infection, can inhibit cap-dependent translation and simultaneously enhance cap-independent initiation. For example, PDAP1 regulates ER stress responses and is required for hepatovirus translation. RNA modifications like m6A can dynamically promote cap-independent translation of specific mRNAs. Additionally, RNA structural elements such as G-quadruplexes can switch from inhibitory to stimulatory roles depending on the presence of an IRES. Viral proteins and host ITAFs also modulate IRES activity.
positive regulation of cap-independent translational initiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDAP1 | Hepatovirus translation and ER stress | Knockout cell lines to study viral translation |
| VEGFA | Lung cancer angiogenesis | Overexpression and m6A-site point mutation models |
| METTL3 | Cancer angiogenesis via m6A | Knockout and overexpression in cancer cell lines |
| YTHDF1 | m6A-dependent translation in cancer | Knockout to assess cap-independent translation |
| Picornavirus IRES | Viral pathogenesis | IRES reporter knock-in models |
Viral infections
Many RNA viruses, including picornaviruses, flaviviruses, and hepatoviruses, depend on positive regulation of cap-independent translational initiation for their gene expression. This makes the process a prime target for antiviral therapies.
Cancer
In lung cancer, m6A modification promotes cap-independent translation of VEGFA, accelerating angiogenesis. Thus, positive regulators of cap-independent initiation can contribute to tumor progression and are potential therapeutic targets.
Stress-related disorders
Dysregulation of cap-independent translation may affect cellular stress responses, contributing to diseases such as neurodegeneration, although direct evidence is still emerging.
From positive regulation of cap-independent translational initiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is PDAP1 required for hepatovirus translation? | PDAP1 knockout cell lines |
| Does m6A at a specific site promote VEGFA translation? | Point mutation of m6A site in VEGFA |
| Can a reader protein be tagged to track translation? | Tagged knock-in of YTHDF1 |
| Does overexpression of an ITAF enhance IRES activity? | Overexpression of PTBP1 or PCBP2 |
| What is the role of a 3' CITE in translation? | Knock-in of 3' CITE reporter |
| Can CRISPR screen identify novel positive regulators? | Genome-wide CRISPR library screening |
How to Study the positive regulation of cap-independent translational initiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy on mRNAs | Global translation profiling |
| RNA-seq | mRNA abundance | Transcriptome analysis |
| Proteomics | Protein expression levels | Validation of translation changes |
| Dual-luciferase reporter | IRES or CITE activity | Quantifying cap-independent initiation |
| m6A-seq | m6A modification sites | Identifying m6A-regulated translation |
| CRISPR screen | Gene essentiality for translation | Discovery of novel regulators |
| CLIP-seq | RNA-binding protein sites | Mapping ITAF interactions |
| Polysome profiling | mRNA distribution in polysomes | Assessing translation efficiency |
Ribosome profiling (Ribo-seq)
Ribo-seq provides a genome-wide snapshot of translation by sequencing ribosome-protected mRNA fragments. It can identify mRNAs translated cap-independently under specific conditions.
RNA-seq and transcriptomics
RNA-seq measures steady-state mRNA levels, which when combined with Ribo-seq can reveal changes in translational efficiency.
Proteomics
Mass spectrometry-based proteomics quantifies protein output and can validate changes in cap-independent translation.
Reporter assays
Bicistronic or monocistronic reporters containing IRESs or 3' CITEs are used to measure cap-independent initiation activity.
How CRISPR Can Be Used to Study GO:1903679 positive regulation of cap-independent translational initiation
Knockout
CRISPR knockout of candidate positive regulators, such as PDAP1 or METTL3, can abolish cap-independent translation and reveal their necessity.
Point Mutation
Introducing point mutations in RNA elements (e.g., m6A sites) or protein domains can dissect their specific contributions to cap-independent initiation.
Knock-in
Knock-in of tagged versions of proteins (e.g., YTHDF1) or reporter constructs with IRESs allows tracking and quantification of cap-independent translation in live cells.
Overexpression
Overexpression of ITAFs or initiation factors can enhance cap-independent translation and test sufficiency.
How EDITGENE Supports positive regulation of cap-independent translational initiation Research
Researchers studying positive regulation of cap-independent translational initiation-related genes often need to determine whether a candidate gene is causally involved in this process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cap-independent translational initiation research.
Frequently Asked Questions About positive regulation of cap-independent translational initiation
What is GO:1903679?
GO:1903679 is a Gene Ontology term for any process that activates or increases the frequency, rate or extent of cap-independent translational initiation.
What genes are involved in positive regulation of cap-independent translational initiation?
Key genes include PDAP1, VEGFA, METTL3, YTHDF1, and various ITAFs like PTBP1.
How does cap-independent translation initiation work?
It bypasses the 5' cap by using RNA structures like IRESs or 3' CITEs to recruit ribosomes directly.
Why is cap-independent translation important in viral infections?
Many RNA viruses rely on it to translate their proteins when cap-dependent translation is shut down.
What role does m6A play in cap-independent translation?
m6A modification can promote cap-independent translation of specific mRNAs, such as VEGFA in cancer.
What diseases are associated with dysregulated cap-independent translation?
Viral infections and cancer, particularly angiogenesis in lung cancer.
How can CRISPR be used to study cap-independent translation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators.
What methods measure cap-independent translational initiation?
Ribo-seq, dual-luciferase reporters, polysome profiling, and m6A-seq are commonly used.
What is the role of PDAP1 in translation?
PDAP1 is an eIF4E-binding protein that regulates ER stress and is required for hepatovirus translation.
Can cap-independent translation be targeted therapeutically?
Yes, it is a potential target for antiviral and anticancer therapies, though more research is needed.
Conclusion
GO:1903679, positive regulation of cap-independent translational initiation, is a critical biological process that enables protein synthesis when cap-dependent translation is compromised. It is exploited by viruses and contributes to cancer progression, making it a promising therapeutic target. Advances in CRISPR models and translation profiling are accelerating our understanding of its regulators and mechanisms.
References
- 1. Shirasaki T et al.. 2024. Hepatovirus translation requires PDGFA-associated protein 1, an eIF4E-binding protein regulating endoplasmic reticulum stress responses.. Sci Adv 10(47):eadq6342 PMID: 39565848
- 2. Nicholson BL et al.. 2011. 3' Cap-independent translation enhancers of positive-strand RNA plant viruses.. Curr Opin Virol 1(5):373-80 PMID: 22440838
- 4. Bedard KM et al.. 2004. Regulation of picornavirus gene expression.. Microbes Infect 6(7):702-13 PMID: 15158778
- 5. Hoque ME et al.. 2022. Reversal of G-Quadruplexes' Role in Translation Control When Present in the Context of an IRES.. Biomolecules 12(2) PMID: 35204814
- 6. Zhang H et al.. 2023. N6-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer.. Cancer Res 83(13):2208-2225 PMID: 37103476
- 7. Berzal-Herranz A et al.. 2022. The Genomic 3' UTR of Flaviviruses Is a Translation Initiation Enhancer.. Int J Mol Sci 23(15) PMID: 35955738
- 8. Lu G et al.. 2025. Roles of RNA Structures in the Genome Translation of (+) Sense RNA Viruses.. Viruses 17(11) PMID: 41305427
